Chart Showing XBI breakdown 9-3-20 thru 9-4-20Broader Market ConditionsBetween yesterday and today the broader markets have been in a free-fall and the biotech sector was not immune despite missing … [Read more...] about Volatility Update 9-4-20
Market Updates
Biopharma Stock Watch June 17th-21st
MS Performance Tracker Showing Data From Friday June 14th After The Market Closed Two weeks into June the markets are continuing to recover from the painful volatility we experienced in April and … [Read more...] about Biopharma Stock Watch June 17th-21st
The Next Catalyst for TG Therapeutics
Recently, TG Therapeutics (TGTX) reported positive results from its Phase 2b registrational directed trial UNITY-NHL study. Updated results from this study were presented at AACR earlier this year, … [Read more...] about The Next Catalyst for TG Therapeutics
Biopharma Stock Watch June 3rd-7th
May 27th-31st we saw a continuation of brutal market volatility spurred by an escalating trade war with china, new tariffs, and rhetoric of war with Iran. Trade negotiations earlier this month ended … [Read more...] about Biopharma Stock Watch June 3rd-7th
Lackluster ASCO Results for Verastem and AVEO – Part 2
As discussed in part one of this two part series, both Verastem and AVEO appear to be going to the ASCO conference this weekend with minimal updates pertaining to their pipeline. With volatility and a … [Read more...] about Lackluster ASCO Results for Verastem and AVEO – Part 2
Lackluster ASCO for Verastem and AVEO
Given Verastem's (VSTM) depressing price movement since reaching $10 in 2018 and AVEO's volatile start to 2019, neither company has brought forth any interesting data for presentation at ASCO 2019. … [Read more...] about Lackluster ASCO for Verastem and AVEO
Investor Alert: Endra Life Scienes (NDRA)
Background Endra Life Sciences (NDRA) is a clinical stage medical device company we started following in April, 2019. The share price galloped up to a high near $3.30 in March in anticipation of … [Read more...] about Investor Alert: Endra Life Scienes (NDRA)
Biopharma Stock Watch May 20th-24th
The past week of trading was a mixed bag. On Monday we saw what I would call a "flash crash". The DJI dropped over 600 points in the morning (-2.4%) and proceeded to have its worst day this year since … [Read more...] about Biopharma Stock Watch May 20th-24th
ALERT: This Stock Has Been Beat Up, But Could Jump at ASCO
The summer oncology conferences are drawing nearer, and so to is the abstract release date for ASCO. For a complete overview of the timeline and abstract titles I am watching, check out my previous … [Read more...] about ALERT: This Stock Has Been Beat Up, But Could Jump at ASCO
Biopharma Stock Watch May 13th-17th
The trade talks between the U.S. and Chinese officials have come and gone leaving no trade deal in place. While U.S markets were not rocked as hard as Asia's it was a still a relatively bloody week. … [Read more...] about Biopharma Stock Watch May 13th-17th
You must be logged in to post a comment.